Labeled for this condition
Medicines for nerve pain and fibromyalgia
6 medicines have an FDA label indicated for nerve pain and fibromyalgia; 5 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for nerve pain and fibromyalgia?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Gabapentin | Neurontin, Gralise, Relgaabi | 85 labelers | $0.0218 per capsule 100 mg capsule | No | No current entry | 22 |
| Pregabalin | Lyrica | 52 labelers | $0.0571 per capsule 100 mg capsule | No | No current entry | 5 |
| Cyclobenzaprine | Amrix, Tonmya, Fexmid | 59 labelers | $0.0171 per tablet 10 mg tablet | No | No current entry | 5 |
| Duloxetine | Drizalma | 45 labelers | $0.102 per capsule 30 mg capsule | Yes | No current entry | 56 |
| Milnacipran | Savella | 4 labelers | $2.82 per tablet 100 mg tablet | Yes | No current entry | 0 |
| Gabapentin enacarbil | Horizant | none listed | $17.93 per tablet 300 mg tablet | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price